Opendata, web and dolomites

ID-Lyme SIGNED

A novel immunity-based test for early diagnosis of Lyme disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "ID-Lyme" data sheet

The following table provides information about the project.

Coordinator
M-4 GROEP BV 

Organization address
address: KRAAIVENSTRAAT 25-18
city: TILBURG
postcode: 5048 AB
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website http://id-lyme.eu
 Total cost 2˙609˙503 €
 EC max contribution 1˙913˙690 € (73%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2. (PRIORITY 'Industrial leadership')
 Code Call H2020-FTIPilot-2015-1
 Funding Scheme IA
 Starting year 2016
 Duration (year-month-day) from 2016-07-01   to  2020-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    M-4 GROEP BV NL (TILBURG) coordinator 18˙375.00
2    INNATOSS LABORATORIES BV NL (OSS) participant 819˙247.00
3    NPK DESIGN BV NL (LEIDEN) participant 433˙440.00
4    DIARECT AG DE (FREIBURG IM BREISGAU) participant 352˙502.00
5    MEDIZINISCHE UNIVERSITAET WIEN AT (WIEN) participant 290˙125.00

Map

 Project objective

The main objective of this ID-Lyme project was to push to the market a novel test, the Ixodes kit, for the early detection of Lyme Borreliosis (LB), also known as Lyme disease. LB can usually be treated using cost-effective antibiotics at an early stage of disease. Unfortunately, standard laboratory testing is often unable to give a clear diagnosis whether a patient is infected or not. This can result in the true infection remaining untreated. This is a significant healthcare concern because of the disabling effects and the much costlier and more challenging treatment of progressive disease. This project was to deliver to the market the first point-of-care diagnostic test that can identify LB infections in the early stage prior to the onset of symptoms thereby improving LB management and patient health outcomes as well as reducing LB-related healthcare costs. When successful, the project would have significant impact on EU healthcare and society, as currently over 2.6 million tests are performed in the EU each year on people suspected of LB infection.

With support of the Fast Track to Innovation program by Horizon2020, a dedicated consortium of in vitro diagnostic assay developers (Innatoss Laboratories), production specialists (NPK, Diarect) and clinical experts (Medical University of Vienna) will finalize the kit design, upscale production, and test the product under real-life conditions to prepare the kit for EU-wide market introduction and implementation. The Ixodes kit will result in: 1. early and effective treatment of patients; 2. quality of life of patients; and 3. large direct and indirect cost reductions on a EU-wide level.

Unfortunately, the discriminatory power of the Ixodes test was insufficient to progress to the intended performance study. Instead, the WOLF device that has been developed as part of the Ixodes kit will aim for development of kit components as stand-alone diagnostic tools that will have broad application for whole blood tests.

 Deliverables

List of deliverables.
Project update IV to LB patient organization - ABANDONED Websites, patent fillings, videos etc. 2020-04-08 09:35:34
Project update III to LB patient organizations Websites, patent fillings, videos etc. 2020-04-08 09:35:34
Project update II to LB patient organizations Websites, patent fillings, videos etc. 2020-04-08 09:35:34
Project update I to LB patient organizations Websites, patent fillings, videos etc. 2020-04-08 09:35:34
Project website Websites, patent fillings, videos etc. 2020-04-08 09:35:34

Take a look to the deliverables list in detail:  detailed list of ID-Lyme deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ID-LYME" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ID-LYME" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.)

Innovation Principle (2019)

Developing an Innovation-Friendly Legislative Culture – the Innovation Principle at Work

Read More  

PULSe (2017)

Pervasive Ubiquitous Lightwave SEnsor

Read More  

MedEye (2017)

Accelerated market launch of MedEye, a plug-and-play medication safety solution

Read More